Physician profile
John Roxborough
NPI 1033630124
$340.61
in general payments reported to CMS, 2019-2025
9 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.47 · 2023: $112 · 2024: $29.71 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $76.99 | 2025 | Zepbound, Mounjaro |
| Gilead Sciences, INC. | $55.71 | 2022-2023 | |
| Exact Sciences Corporation | $53.44 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $45.52 | 2022-2023 | Delstrigo, Pifeltro |
| Takeda Pharmaceuticals U.S.A., INC. | $29.71 | 2024 | Glassia |
| Janssen Biotech, INC. | $27.25 | 2023 | Symtuza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.00 | 2022 | |
| Pfizer INC. | $18.77 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.22 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roxborough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.